NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Thursday that first quarter revenues increased 27 percent, and that the firm achieved the first quarter of positive operating cash flow in its history.

For the three months ended March 31, the Seattle-based molecular diagnostics firm reported total revenues of $14.7 million, compared to $11.6 million in the prior year period. However, revenue fell short of the average Wall Street analyst estimate of $14.9 million. Foreign exchange rates affected growth by less than 1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.